Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001188112-10-001299
Filing Date
2010-05-13
Accepted
2010-05-13 16:52:03
Documents
5
Group Members
DANIEL J. DONOGHUEMICHAEL MURPHY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D t68044_sc13d.htm SC 13D 122409
2 EXHIBIT 1 ex1.htm EX-1 68758
3 EXHIBIT 2 ex2.htm EX-2 12949
4 EXHIBIT 3 ex3.htm EX-3 8924
5 EXHIBIT 4 ex4.htm EX-4 8916
  Complete submission text file 0001188112-10-001299.txt   224086
Mailing Address 11 STUDEBAKER IRVINE CA 92618
Business Address 11 STUDEBAKER IRVINE CA 92618 9495957200
ENDOLOGIX INC /DE/ (Subject) CIK: 0001013606 (see all company filings)

EIN.: 680328265 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-48781 | Film No.: 10829279
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 191 N. WACKER DRIVE SUITE 1685 CHICAGO IL 60606
Business Address 191 N. WACKER DRIVE SUITE 1685 CHICAGO IL 60606 (312) 265-96000
Discovery Group I, LLC (Filed by) CIK: 0001312548 (see all company filings)

EIN.: 300075077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D